Lateral Capital

Lateral Capital is a New York-headquartered VC investing in tech-enabled businesses across Sub-Saharan Africa, with a deliberate focus on highly scalable models addressing fundamental gaps in healthcare, financial services, and infrastructure. Check sizes are in the $1M to $5M range across seed and Series A, and the firm’s healthcare interest spans digital health, health IT software, and AI applications. The Lateral team brings a US-based operating sensibility paired with deep on-the-ground networks across Lagos, Nairobi, Accra, and Kigali, which gives it a bridging role for African founders who need access to US capital and operating expertise without losing local relevance. The geographic focus is Sub-Saharan Africa, with active deal flow concentrated in Nigeria, Kenya, Ghana, and Rwanda. The right founder profile is an African founder with strong local operating instincts, building infrastructure or services that materially expand access to healthcare in Sub-Saharan markets, with a credible path to multi-country scale and a US institutional fundraising trajectory beyond Lateral. The wrong fit is a Western-market-first company that lists Africa as an aspirational expansion plan, or a deep-tech biotech; Lateral is a tech-enabled commercial investor focused on solving distribution and access problems. The right entry path is through Lagos and Nairobi founder networks, through warm introductions from co-investors at TLcom Capital, Partech Africa, Novastar Ventures, and Future Africa, and through US-based Africa-focused operator and investor communities including African Business Angels Network. When pitching, lead with the local market insight, the unit economics that work at African price points, and the AI or technology capability that materially changes the cost-to-serve or clinical outcome rather than serving as a marketing veneer. Then connect to multi-country expansion logic. Caveats: Lateral is one of multiple credible Africa-focused VCs and does not bring the deepest healthcare specialist operating expertise, so founders should layer healthtech-specialist co-investors onto the cap table. The firm’s US headquarters also means founders should expect US-style governance norms and reporting cadence, which can be a feature for downstream fundraising or a friction point for founders who prefer lighter-touch partners. Use Lateral when you need a US-bridging Africa partner with credible local depth and a network of US institutional investors for the next round.